general
Archived signal Translated · English · 2–5m lag
Suspension of self-immune diseases treatment after fatal fatal side effects and failure
Suspension of clinical trials by Novartis and Bristol Myers has triggered a career to understand why a promising self-immune treatment has become more likely to take Leer
Reported by El Mundo
Read the complete report at El Mundo ↗
Verification notice
IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.
2 reports · 2 sources
El MundoSuspension of self-immune diseases treatment after fatal fatal side effects and failureEl MundoSuspension of self-immune diseases treatment after fatal fatal side effects and failure9 recorded states
Signal first indexedP1 · 68% quality · 1 source
Corroboration 1→2 sources · quality 68→72P1 · 72% quality · 2 sources
Quality 72→76P1 · 76% quality · 2 sources
Quality 76→80P1 · 80% quality · 2 sources
Quality 80→84P1 · 84% quality · 2 sources
Quality 84→88P1 · 88% quality · 2 sources
Quality 88→92P1 · 92% quality · 2 sources
Quality 92→96P1 · 96% quality · 2 sources
Quality 96→99P1 · 99% quality · 2 sources